Stéphanie Durand

Biophysical properties of the clinical-stage antibody landscape

Tushar Jain, Tingwan Sun, Stéphanie Durand et al. · Proceedings of the National Academy of Sciences · 2017 · 634 citations · Full text

Pharmacy, Biotechnology, Medicinal Chemistry +17

APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells

Grégory Berger, Stéphanie Durand, Guillaume Fargier et al. · PLoS Pathogens · 2011 · 197 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity

Kévin Tartour, Romain Appourchaux, Julien Burlaud‐Gaillard et al. · Retrovirology · 2014 · 136 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1–derived lentiviral vectors

G Berger, Stéphanie Durand, Caroline Goujon et al. · Nature Protocols · 2011 · 97 citations

Life Sciences, Immunology, Infectious Diseases +16

Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells

Flaria El Khoury, Laurent Corcos, Stéphanie Durand et al. · International Journal of Oncology · 2016 · 68 citations

Medicine, Oncology, Pharmacology +17